About 2 Million Updated mRNA COVID-19 Vaccines Administered

According to Reuters reporting, about 1.8 million people in the United States received an updated mRNA COVID-19 vaccine during the week ended September 22, 2023, according to data compiled by IQVIA Holdings Inc.

Moderna Inc. and Pfizer, Inc.'s newly approved vaccines are meeting pent-up consumer demand who are preparing for the forthcoming respiratory disease season in the U.S.

These mRNA vaccines are generally available in U.S.-based pharmacies and health clinics.

Pharmacies such as Walgreens have recently updated their vaccine appointment scheduling capabilities and related information.

As of October 2, 2023, U.S. agencies have not approved Novavax Inc.'s protein-based COVID-19 Vaccine Adjuvanted (Nuvaxovid™).

These innovative vaccines aspire to prevent the fading COVID-19 pandemic from further impacting the global society.